YNIOS PHARMA

YNIOS PHARMA is a biotech founded in March 2022 by Philippe Van Wesepoel and Jean François Plucker, the same founders of biotech OLYS Pharma which develops topical neuro-cutaneous treatments. *... YNIOS PHARMA is focusing on Critical Care indications with inflammation-induced cell degeneration, such as Septic Shock, Acute Ischemic Stroke, Acute Myocardial Infarction and Organ Transplantation... YNIOS PHARMA is leading a Critical Care preclinical program to demonstrate its effectiveness in modulating acute systemic inflammatory responses, protecting vital organs and promoting faster patient recovery.

Also known as: YNIOS Pharma srl

VAT numbers: BE 0783.494.239

Primary location: Verlaine Belgium